KLRK1 and hepatocellular carcinoma: NKG2D-based CAR-T cells comprising the extracellular domain of human NKG2D, 4-1BB, and CD3ζ-signaling domains (BBz) effectively eradicated SMMC-7721 HCC xenografts [49].